DUBLIN, Nov. 7, 2023 /PRNewswire/ — The “China Pharmaceutical Companies and Drugs Pipeline Insight 2023” drug pipelines has been added to ResearchAndMarkets.com’s offering.
Chinese drugs makers have advanced significantly in the global pharmaceutical market over the previous two decades, becoming reliable partners for drug development and helping make China another key region in the global pharma market. BeiGene, Innovent Bio, Akeso, and Junshi Biosciences are among the country’s leading pharmaceutical market players.
Many Chinese pharmaceutical companies have made a name for themselves in the global drug market by developing breakthrough medications and therapies that have integrated advanced science and medicine technologies and platforms. Based on current pharmaceutical market trends in the country, it is considered that China has the ability to compete with the major markets…
